Dr. Mitul Gandhi
Claim this profileVirginia Cancer Specialists
Studies B-Cell Lymphoma
Studies Acute Myelogenous Leukemia
18 reported clinical trials
32 drugs studied
Area of expertise
1B-Cell Lymphoma
MYC positive
BCL6 positive
BCL2 positive
2Acute Myelogenous Leukemia
FLT3 positive
NPM1 positive
KMT2A (MLL)-fusion positive
Affiliated Hospitals
Clinical Trials Mitul Gandhi is currently running
DSP-5336
for Leukemia
This trial is testing a new drug called DSP 5336 to help treat adults with certain types of blood cancer that have come back or didn't respond to previous treatments. The study will first find the best amount to give and then check how safe and helpful it is.
Recruiting1 award Phase 1 & 215 criteria
Cema-cel
for B-Cell Lymphoma
This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic CD19 CAR T product, as compared to standard of care observation. In this study, participants with MRD are randomized 1:1 to treatment with cema-cel or an observation arm. Treatment includes cema-cel following a lymphodepletion regimen of fludarabine and cyclophosphamide. Prior to August 2025, participants may also have received an anti-CD52 monoclonal antibody, ALLO-647, as part of their lymphodepletion regimen.
Recruiting1 award Phase 25 criteria
More about Mitul Gandhi
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mitul Gandhi has experience with
- Rituximab
- Lenalidomide
- Selinexor
- Tazemetostat
- LOXO-305
- Venetoclax
Breakdown of trials Mitul Gandhi has run
B-Cell Lymphoma
Acute Myelogenous Leukemia
Lymphoma
Multiple Myeloma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitul Gandhi specialize in?
Mitul Gandhi focuses on B-Cell Lymphoma and Acute Myelogenous Leukemia. In particular, much of their work with B-Cell Lymphoma has involved MYC positive patients, or patients who are BCL6 positive.
Is Mitul Gandhi currently recruiting for clinical trials?
Yes, Mitul Gandhi is currently recruiting for 4 clinical trials in Gainesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mitul Gandhi has studied deeply?
Yes, Mitul Gandhi has studied treatments such as Rituximab, Lenalidomide, Selinexor.
What is the best way to schedule an appointment with Mitul Gandhi?
Apply for one of the trials that Mitul Gandhi is conducting.
What is the office address of Mitul Gandhi?
The office of Mitul Gandhi is located at: Virginia Cancer Specialists, Gainesville, Virginia 20155 United States. This is the address for their practice at the Virginia Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.